FY2025 EPS Estimate for Option Care Health Lifted by Analyst

Option Care Health, Inc. (NASDAQ:OPCH) – Barrington Research boosted their FY2025 earnings per share estimates for shares of Option Care Health in a note issued to investors on Wednesday, April 30th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings of $1.50 per share for the year, up from their prior estimate of $1.47. Barrington Research has a “Outperform” rating and a $38.00 price target on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.22 per share. Barrington Research also issued estimates for Option Care Health’s Q1 2026 earnings at $0.36 EPS, Q2 2026 earnings at $0.41 EPS and Q3 2026 earnings at $0.43 EPS.

OPCH has been the subject of a number of other reports. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JMP Securities reissued a “market outperform” rating and issued a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. UBS Group raised shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $38.00 to $40.00 in a report on Wednesday. JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Finally, Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $35.50.

Option Care Health Stock Up 2.4 %

Shares of NASDAQ OPCH opened at $32.95 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a market cap of $5.41 billion, a P/E ratio of 27.69, a P/E/G ratio of 2.30 and a beta of 1.07. Option Care Health has a 52 week low of $21.39 and a 52 week high of $35.53. The business has a 50-day simple moving average of $33.35 and a two-hundred day simple moving average of $28.85.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same period in the prior year, the company posted $0.26 EPS. Option Care Health’s revenue was up 16.3% compared to the same quarter last year.

Insider Activity at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Barclays PLC grew its stake in shares of Option Care Health by 180.1% during the third quarter. Barclays PLC now owns 310,194 shares of the company’s stock valued at $9,708,000 after buying an additional 199,454 shares during the last quarter. Central Pacific Bank Trust Division boosted its stake in shares of Option Care Health by 6.9% during the fourth quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company’s stock valued at $234,000 after purchasing an additional 650 shares during the period. Nordea Investment Management AB grew its holdings in shares of Option Care Health by 6.0% in the fourth quarter. Nordea Investment Management AB now owns 94,641 shares of the company’s stock worth $2,165,000 after purchasing an additional 5,365 shares during the last quarter. Harbor Capital Advisors Inc. increased its stake in shares of Option Care Health by 2.7% in the fourth quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company’s stock worth $4,945,000 after buying an additional 5,595 shares during the period. Finally, Graypoint LLC purchased a new stake in Option Care Health during the 4th quarter valued at $1,161,000. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.